Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BIOLIFE SOLUTIONS INC

Get SEC filing alerts via email and in your feed for BIOLIFE SOLUTIONS INC

BLFS

BIOLIFE SOLUTIONS INC

About BIOLIFE SOLUTIONS INC

BioLife Solutions, Inc. develops and manufactures bioproduction products and services that support cell and gene therapy (CGT) manufacturing and distribution. Its portfolio includes proprietary biopreservation media, cell processing tools, automated thawing devices, and cloud-connected cold chain shipping containers. Serving biopharma and research customers globally, BioLife’s products enhance biologic material viability, extend shelf-life, and improve process consistency, leveraging cGMP manufacturing and scientific expertise to reduce risks in CGT workflows.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BIOLIFE SOLUTIONS INC

1
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports 25% Revenue Growth to $27.5 Million in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports $96.2 Million Revenue for Fiscal Year 2025, Driven by Biopreservation Media Sales

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports 31% Revenue Growth to $28.1 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports 29% Revenue Growth in Q2 2025 Despite Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports 30% Revenue Growth to $23.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports $82.3 Million Revenue for Fiscal Year 2024, Achieving 8% Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
BIOLIFE SOLUTIONS INC BioLife Solutions Reports 30% Revenue Growth, Reduced Operating Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments